Search trials for
Showing NN of NN trials
Enrolling

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disea...

The study will evaluate the effect of LY3002813 on brain scans. The study will evaluate the safety of LY3002813 by...

Enrolling

Efficacy and Safety of MMFS in Mild AD

This study is designed to evaluate the safety and efficacy of MMFS for improving cognition and global function in patients...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascendin...

This Phase I clinical study is a randomized, double-blind, placebo-controlled, parallel-design study to thoroughly assess the safety profile and PK...

Enrolling

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the clinical efficacy, safety, pharmacokinetics, and pharmacodynamics of ...

Enrolling

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia...

The purpose of this study is to assess the safety, tolerability, biomarker and cognitive efficacy of investigational products in subjects...

Enrolling

Addressing Dementia Via Agitation-Centered Evaluation

This is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of...

Enrolling

European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LC...

Brain changes associated with Alzheimer's disease may precede symptoms of Alzheimer's Dementia by over 20 years. The Investigators hope to...

Enrolling

A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alz...

This study will be conducted to evaluate the efficacy of BAN2401 in participants with early Alzheimer's disease (EAD) by determining...

Enrolling

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated...

To evaluate the safety of brexpiprazole 1 mg or 2 mg after a 14 week treatment regimen for agitation associated...

Enrolling

Brexpiprazole for the Treatment of Patients With Agitation Associated With Demen...

To evaluate the superiority of brexpiprazole 1 mg or 2 mg over placebo after a 10-week treatment regimen for agitation...

Not Yet Enrolling

A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With A...

The primary objective is to evaluate the long-term safety and tolerability of aducanumab after a wash-out period imposed by discontinuation...

Not Yet Enrolling

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moder...

This is Phase 3 study, multi-centre, double-blind, placebo controlled, parallel group to evaluate the effects of AC-SD-03 on the efficacy...